Increased osteoprotegerin and decreased pyridinoline levels in patients with ankylosing spondylitis: Comment on the article by Gratacós et al
- 12 December 2002
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (12) , 3390-3392
- https://doi.org/10.1002/art.10562
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone ResorptionJournal of Bone and Mineral Research, 2000
- Significant loss of bone mass in patients with early, active ankylosing spondylitis: A followup studyArthritis & Rheumatism, 1999
- Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptidesClinical Chemistry, 1998
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- A single measurement of biochemical markers of bone turnover has limited utility in the individual personScandinavian Journal of Clinical and Laboratory Investigation, 1997
- New York clinical criteria for ankylosing spondylitis. A statistical evaluation.Annals of the Rheumatic Diseases, 1973